Repligen Corp. (RGEN)

167.93 -2.04 (-1.20%) USD  |  NASDAQ  |  Jan 22, 16:00
166.93 -1.00 (-0.60%) Pre-Market: 09:25
More

Repligen Amortization Expense CF (Quarterly)

Amortization Expense CF (Quarterly) Chart

View Amortization Expense CF (Quarterly) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (Quarterly) Range, Past 5 Years

View Amortization Expense CF (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (Quarterly) Benchmarks

View Amortization Expense CF (Quarterly) Benchmarks
Start Trial
Enovis Corp. Upgrade
Perspective Therapeutics, Inc. --
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
VolitionRX Ltd. Upgrade